AstraZeneca buys Pfizer gene therapy portfolio for $1bn as profits soarRare diseases are conditions defined as affecting fewer than 1...
AstraZeneca
AstraZeneca shares fall 8% following disappointing results from trials of its new lung cancer drugBy Calum Muirhead For The Daily...
AstraZeneca plotting to hive off its China division amid rising tensions between Beijing and the WestBy Calum Muirhead For The...
Pharma giant AstraZeneca signs huge deal with UK start-up to create treatments for diabetes and other autoimmune diseasesBy Calum Muirhead...
AstraZeneca boasts positive results from drug trial involving late-stage endometrial cancer patientsAstraZeneca earned over $4bn in revenues from Imfinzi and Lynparza...
'Very unattractive' Britain leaves drugmaker AstraZeneca eyeing China as the next big growth regionBy Calum Muirhead For The Daily Mail...
Investors urged to oust Astra boss Soriot as pharma giant is hit with raft of high-profile legal claimsBy Luke Barr...
The coroner at Stephen Wright's inquest described it as a "very unusual and deeply tragic case". Source link
Get the free Morning Headlines email for news from our reporters across the worldSign up to our free Morning Headlines...
AstraZeneca chief exec Pascal Soriot earns £120m in 10 years after raking in £15.3m in 2022By Mark Shapland For The...